Skip to content
Modern WisdomModern Wisdom

PROFESSOR DAVID SINCLAIR | Can Humans Live For 1000 Years?

David Sinclair is a Professor in the Department of Genetics at Harvard Medical School and co-Director of the Paul Glenn Centre for the Biological Mechanisms of Ageing. Today we hear from a scientist at the cutting edge of longevity research as Professor Sinclair gives us a fascinating insight into the world of anti-ageing. Expect to learn how and why we age, why stabilising the epigenetic landscape may enable a human to live for 1000 years, exactly what tactics Professor Sinclair is using himself to try and extend his life and how fasting, Sirtuins and NAD can be used to promote health and reduce diseases. Extra Stuff: David’s New Book - http://lifespanbook.com/ Follow David on Twitter - https://twitter.com/davidasinclair Inside Tracker - https:// www.insidetracker.com Recommended Books - https://www.amazon.co.uk/shop/modernwisdom Nick Bostrom on Sam Harris - https://podcasts.apple.com/gb/podcast/making-sense-with-sam-harris/id733163012?i=1000432217348 - Listen to all episodes online. Search "Modern Wisdom" on any Podcast App or click here: iTunes: https://apple.co/2MNqIgw Spotify: https://spoti.fi/2LSimPn Stitcher: https://www.stitcher.com/podcast/modern-wisdom - I want to hear from you!! Get in touch in the comments below or head to... Twitter: https://www.twitter.com/chriswillx Instagram: https://www.instagram.com/chriswillx Email: modernwisdompodcast@gmail.com

Chris WilliamsonhostDavid Sinclairguest
Apr 22, 20191h 14mWatch on YouTube ↗

CHAPTERS

  1. 0:01 – 2:12

    At Harvard: InsideTracker results and why “biological age” matters

    Chris meets David Sinclair at Harvard Medical School and they open with a practical hook: Chris’s InsideTracker results show a biological age older than his chronological age. This sets up the central theme that aging can be measured, influenced, and potentially reversed.

  2. 2:12 – 5:37

    Sinclair’s lab and the aging-research ecosystem (academia + biotech)

    Sinclair explains what his lab does day-to-day and how Harvard’s basic science connects to a broader network of companies and collaborators. He emphasizes translating discoveries into real-world interventions rather than stopping at publications.

  3. 5:37 – 6:49

    Is there an “anti-aging pill”? Why slowing aging may be easier than curing cancer

    They discuss the plausibility of a broad intervention that targets aging itself rather than one disease at a time. Sinclair argues that the field now understands core levers of aging and expects human trials aimed at reversing cellular age.

  4. 6:49 – 8:23

    Three intervention strategies: defenses, senescent cells, and partial reprogramming

    Sinclair outlines three major approaches to extending healthspan and lifespan. He positions partial cellular reprogramming as the newest and most powerful, with the potential to reverse cellular age rather than only slow decline.

  5. 8:23 – 10:06

    Optic-nerve regeneration in mice: reversing age to restore function

    Sinclair describes breakthrough experiments where reprogramming factors helped damaged optic nerves regrow and restored vision in older mice. The conversation highlights why these results feel like science fiction but are grounded in lab demonstrations.

  6. 10:06 – 14:23

    The epigenetic clock and the “tennis game” model of aging (information loss)

    Sinclair explains aging as a loss of epigenetic information—cells gradually ‘forget’ their identity as repair processes shuffle control proteins around the genome. This model motivates the idea that youthfulness is stored and can be re-accessed.

  7. 14:23 – 24:29

    Public interest, long-form science, and fear of death as a driver

    They discuss why longevity is capturing public imagination and how long-form podcasts counter hype and misreporting. Sinclair argues much interest is rooted in mortality anxiety, but also in the new realism of aging interventions.

  8. 24:29 – 30:21

    Ethics and safety: CRISPR babies, consent, and “enhancement” slippery slopes

    The conversation shifts to governance and ethics of genetic engineering—especially germline edits that affect future generations. They compare disease prevention with elective enhancements and explore where society might draw lines.

  9. 30:21 – 32:58

    Chimeras, organ supply, and the real-world tradeoffs of bioengineering

    Chris asks about sensational claims (human-animal hybrids), and Sinclair clarifies what chimeras are and why some uses feel unethical. They then move to pragmatic applications like virus-free pig organs for transplantation.

  10. 32:58 – 36:59

    What you can do now: eat less, fast, and trigger longevity pathways

    Sinclair gives foundational lifestyle guidance, prioritizing eating less and intermittent fasting. He connects these behaviors to conserved longevity pathways seen across species and explains why timing and quantity can matter as much as food choice.

  11. 36:59 – 49:09

    Mechanisms: sirtuins, NAD, mTOR/AMPK, and the survival tradeoff

    They go deeper on how fasting works biologically, focusing on sirtuins and NAD as central regulators of repair and gene control. Sinclair also explains ‘disposable soma’ tradeoffs between growth/reproduction and long-term maintenance.

  12. 49:09 – 55:28

    Practical stack and cautions: exercise, metformin, NAD boosters, resveratrol, hormones

    Sinclair lists his personal regimen—exercise (especially intervals), metformin, NAD boosters, and resveratrol—while repeatedly stressing uncertainty and risk. They also discuss growth hormone/testosterone, emphasizing limited evidence and potential tradeoffs.

  13. 55:28 – 1:00:31

    When to start longevity interventions: aging begins before birth, but start early after adulthood

    Sinclair explains new evidence that epigenetic aging begins prenatally and can be influenced by early-life development and maternal environment. For interventions, he argues the best ‘bang for buck’ in animal data comes from starting soon after adulthood.

  14. 1:00:31 – 1:04:48

    Big-picture mission: aging as disease, funding urgency, economics, and population fears

    Sinclair describes his motivation to reinvest resources into progress and argues that extending healthspan could save trillions by reducing disease burden. They address overpopulation concerns and suggest demographic trends are driven more by birth rates than longevity.

  15. 1:04:48 – 1:14:39

    Can humans live 1000 years? Rejuvenation cycles via reprogramming and “longevity escape velocity”

    They end on the provocative question of extreme lifespan and Sinclair argues there may be no fixed biological limit. He describes a plausible future where reprogramming factors are switched on periodically to reset aging, potentially enabling repeated rejuvenation over centuries.

Get more out of YouTube videos.

High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.